Related Experiment Video

Updated: Jun 23, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Molecular signatures of breast cancer--predicting the future

Anne Kallioniemi

    The New England Journal of Medicine
    |December 20, 2002
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
    09:01

    Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

    Published on: July 3, 2025

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
    11:12

    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

    Published on: August 1, 2018

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
    09:01

    Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

    Published on: July 3, 2025

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

    Articles linked to this work by shared authors, journal, and citation graph.

    NTHL1 is a recessive cancer susceptibility gene.

    Scientific reports·2023

    Novel ZNF414 activity characterized by integrative analysis of ChIP-exo, ATAC-seq and RNA-seq data.

    Biochimica et biophysica acta. Gene regulatory mechanisms·2022

    A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients.

    Scientific reports·2021

    Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Ovarian Cancer Cells In Vitro.

    Anticancer research·2020

    Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.

    International journal of cancer·2019

    Correction to: Depletion of nuclear import protein karyopherin alpha 7 (KPNA7) induces mitotic defects and deformation of nuclei in cancer cells.

    BMC cancer·2019

    Tozorakimab to Prevent COPD Exacerbations.

    The New England journal of medicine·2026

    An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.

    Neurological research·2026

    Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.

    Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026

    Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.

    Endocrine-related cancer·2026

    Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

    Anesthesiology·2026

    Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

    Cancer cytopathology·2026

    PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.

    Pakistan journal of pharmaceutical sciences·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us